Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
| Company Name | Founded | Funding Stage | Amount | City |
|---|---|---|---|---|
| Hesperos | 2024 | Grant | $2.0M | Orlando |
| Selsym Biotech | 2024 | Grant | $3.0M | Raleigh |
| Annoviant | 2024 | Grant | $3.0M | Alpharetta |
| Magnasense | 2024 | Post Ipo Debt | $711K | La Jolla |
| Enable Biosciences | 2024 | Undisclosed | Undisclosed | South San Francisco |
| SeLux Diagnostics | 2024 | Series D | $48.0M | Charlestown |
| AivoCode | 2024 | Grant | $600K | San Diego |
| Accure Health | 2024 | Non Equity Assistance | Undisclosed | Cambridge |
| Levisonics | 2024 | Grant | $4.3M | Fishers |
| Phase Genomics | 2024 | Grant | $1.5M | Seattle |
| # | Company | Stage | Amount | Location |
|---|---|---|---|---|
| 151 | Hesperos | Grant | $2.0M | Orlando, United States |
| 152 | Selsym Biotech | Grant | $3.0M | Raleigh, United States |
| 153 | Annoviant | Grant | $3.0M | Alpharetta, United States |
| 154 | Magnasense | Post Ipo Debt | $711K | La Jolla, United States |
| 155 | Enable Biosciences | Undisclosed | Undisclosed | South San Francisco, United States |
| 156 | SeLux Diagnostics | Series D | $48.0M | Charlestown, United States |
| 157 | AivoCode | Grant | $600K | San Diego, United States |
| 158 | Accure Health | Non Equity Assistance | Undisclosed | Cambridge, United States |
| 159 | Levisonics | Grant | $4.3M | Fishers, United States |
| 160 | Phase Genomics | Grant | $1.5M | Seattle, United States |
Hesperos, Inc, is a leader in efforts to characterize an individual’s biology with human-on-a-chip microfluidic systems.
Selsym Biotech is a biotechnology developer whose goal is to provide innovative platelet-mimetic therapies for the treatment.
Annoviant is a healthcare company that develops medical devices.
Magnasense will create technology for biomarker assays that are easily accessible.
Enable Biosciences is a biotech company.
SeLux Diagnostics is a developer of a next-generation phenotyping platform that provides personalized antimicrobial therapies to patients.
AivoCode is an emerging biotech focused on critical and highly prevalent diseases affecting the central nervous system
Accure Health develops AI-powered, biomarker-guided solutions that enable precision therapies delivered to the right patients, right cells.
Levisonics is a manufacturer of blood coagulation devices created to perform non-contact analysis of blood coagulation.
Phase Genomics develops a biotechnology platform for new discoveries in agriculture, human health, and industrial biology industries.
Autonomous Medical Devices is a developer of a medical device designed to detect pathogens and viruses.
Behaivior is a digital health company democratizing mental health recovery and wellness using AI, behavioral health tech, and wearables.
Sequentify develops sample processing technologies and solutions for next-generation sequencing, genomic diagnostics, and therapeutics.
The digestive health platform of the future
Sapphiros invests in growth-stage diagnostic companies, focusing on technologies that prioritize innovation and patient-centric approaches.
Prapela is a noninvasive stimuation therapy that improves breathing and oxygenation in newborns.
CaroGen develops vaccine candidates targeting hepatitis B and C, and other viral agents.
Hackensack Meridian Health is a health care organization that offers research and medical services.
Virtuoso Surgical specializes in developing endoscopic robotic tools for minimally invasive surgery.
AI-Driven Robotic Medical Technologies for Sleep Health
Cytonus Therapeutics focuses on developing novel therapeutic solutions using its proprietary drug delivery platform.
Codagenix develops live-attenuated viral vaccines to provide target antigens placed in an attenuated backbone virus.
Microvascular Therapeutics is a biotechnology company specializing in ultrasound contrast and theranostics for diagnosis.
Rational Vaccines is a pre-clinical stage that develops live-attenuated herpes simplex virus vaccines.
Rhaeos is a medical device company that develops wearable sensors to improve the treatment of chronic health conditions.
National Institutes of Health has invested in 288 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
National Institutes of Health's top investment sectors include Health Care, Biotechnology, Medical, Health Diagnostics, Medical Device. The firm invests across 24 different industry categories.
Among tracked funding rounds, SeLux Diagnostics received $48.0M in a Series D round. National Institutes of Health's total known invested capital is $1.3B.
National Institutes of Health's average investment size is $6.6M across its portfolio of 288 companies.
Recent National Institutes of Health portfolio additions include Hesperos, Selsym Biotech, Annoviant, Magnasense, Enable Biosciences. These companies were founded in 2020 or later.
Discover portfolio companies of other leading venture capital firms and investors.
View All Investors